Member Info for iPhoneiTrade

why would he sell if he knew there was news to move up the share price??????????????????
i sold out there. If they're asking you to buy there they must be looking to exit. Be careful

Hold them even at this level - load up

The weak cleared and we move up

The re-rate is on

Demand here is astounding. Only one way me think

It was NT to buy in the 17s.

Did anyone notice that.

£1,000 - No quote

MMs playing a game. drop is only to take shares. not for buyers. always test that. don't get robbed by the MMs.

Loading up - the MMs will clear the weak and move up again.

10:04:25 17.99 100,000 17.99k O
10:04:22 17.99 100,000 17.99k O
10:04:20 17.99 27,793 5,000 O
10:04:20 17.77 1,500 266.55 O
10:04:20 17.77 57,516 10.22k O

The tree shake won't go on for long
Not a lot of shares about so MMs have to find a means.
I think the re-rate will continue.
Getting ready for next level up

20 bid - 20.5 ask.

going much higher folks

later this afternoon.

Been saying again and again - its a re-rate

Going much higher.
Been saying this since 10p yesterday

re-rate continues

load up

SYN00GOLD
i agree.

This will multi bag from here. Those selling this is a pump and dump will regret it.

Like yesterday, when the US come on line, this will go up a huge amount 50 % +

So many great products here and its only headed one way. North.

L2 looking strong

the traders and weak seller being cleared. Its going higher me think

16 on the Ask - This wants to go much higher

Intraday RNS hopefully.

This will do a lot more.

30p is not a ramp here.

Those selling for 20% will be kicking themselves later.

A liver procedure which will stop surgery is huge. The IIs will come on board.

FDA is HUGE

On yesterday's RNS, this is going to 20p.
Add today's and may be more.

NOTE: This went up yesterday at 1:30 and 2:30pm. The US will load up when they come online

New standard of care for the world. HUGE. £0.50p+ in days. CE Mark does not take long so they will get CE Mark, partner with manufacturers and distributors. 183% - You have not seen nothing yet. Hold and load up. This has much more to come. The more i look at this company, the more i like them. Long hold.

LSN's proprietary algorithms process CT images of a patient's liver to assess the nodules along the liver surface. This low cost, low-risk, non-invasive procedure provides physicians with new information that may aid in the staging of CLD and has the potential to become the standard of care for a significant global market.